No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

byTeddy Guo

February 11, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

RelatedReports

AI Roundup

Artificial intelligence matches dermatologists in melanoma diagnosis

September 15, 2025

AI Roundup

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th,  2025]

September 25, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

Chronic Disease

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

August 27, 2025

Preterm infants responsive to PCV13 vaccine

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

Complement mutation linked to poor response to eculizumab

Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Large study outlines risk factors for severe COVID-19 in children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports